Whitehawk Therapeutics Inc. reported that Chief Executive Officer David James Lennon sold a total of 260,427 shares of the company’s common stock in three broker-assisted transactions conducted between April 6 and April 8, 2026. The combined proceeds from those sales totaled approximately $899537.
The individual trades were executed at slightly different price points. On April 6, Lennon sold 102,395 shares at $3.51 per share. The following day he sold 94,087 shares at $3.43. The final block of 63,945 shares changed hands on April 8 at $3.40 each.
Company filings indicate the sales were facilitated by brokers and were carried out to cover tax liabilities tied to the vesting of restricted stock units. Following the transactions, Lennon directly owns 533,122 shares of Whitehawk Therapeutics.
Market context and analyst notes
Despite recent short-term weakness in price action, the stock has recorded notable gains over longer timeframes, appreciating 107% over the last 12 months and 57% over the past six months. Analysis from InvestingPro cited in company disclosure indicates Whitehawk appears undervalued at current market levels. The same analysis highlights that the company holds more cash than debt on its balance sheet, while also flagging cash burn and profitability as areas of concern—these two items are listed among 13 InvestingPro Tips available to subscribers, alongside a comprehensive Pro Research Report.
Implications of the sale
The CEO’s disposition appears transactional in nature, with filings attributing the trades to tax obligations arising from RSU vesting. The broker-assisted nature of the sales is consistent with commonly used mechanisms for executives to satisfy tax withholdings without transferring additional personal funds.
Because the transactions were explicitly tied to tax liabilities and the CEO retains a substantial ownership stake post-sale, the moves reflect a liquidity event rather than an outright exit from ownership. Observers noting valuation or balance-sheet dynamics will likely weigh the insider activity alongside the InvestingPro commentary on cash position and profitability.